Lilian Gremlich

Lilian Gremlich has a wealth of work experience. Lilian began their career as a Kauffrau EFZ at BERNINA International AG in 2008. In 2012, they worked as a Praktikant Quality Control at Aenova. In 2017, they completed a Bachelor Thesis: Transcriptional Effect of Steroidhormones in Zebrafish at Fachhochschule Nordwestschweiz FHNW. In 2018, they completed a Master Thesis: Role of IL-21/IL-21R Signaling in Acute Myeloid Leukemia at the Department for Biomedical Research. In 2020, they worked as a Research Assistant Tumor Immunology at Insel Gruppe. Most recently, in 2021, they began working as a Senior Associate Biology at Bright Peak Therapeutics.

Lilian Gremlich obtained a Kauffrau EFZ (Industriekauffrau) from BERNINA International AG between 2008 and 2011. Lilian then attended Berufsbildungszentrum Weinfelden from 2011 to 2012, where they earned a Berufsmaturität (Vocational Matura) in Gesundheit und Soziales (Health and Social Affairs). From 2013 to 2017, Gremlich studied at the University of Applied Sciences and Arts Northwestern Switzerland FHNW, where they earned a B.Sc. in Molecular Life Sciences in Bioanalytics. Finally, they attended the University of Bern from 2017 to 2020, where they earned an M.Sc. in Molecular Life Sciences in Microbiology/Immunology.